Circulating Tumor DNA (ctDNA) Market Insights and Future Development Projections 2024 – 2032
The Circulating Tumor DNA (ctDNA) market has been witnessing substantial growth in recent years, driven by advancements in liquid biopsy techniques and the increasing demand for non-invasive cancer diagnostics and monitoring. ctDNA refers to the fragments of DNA shed from tumors into the bloodstream, which can be detected and analyzed to assess cancer characteristics. This method...
0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior